Matches in Wikidata for { <http://www.wikidata.org/entity/Q92450363> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q92450363 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92450363 description "im Mai 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92450363 description "scientific article published on 01 May 2019" @default.
- Q92450363 description "wetenschappelijk artikel" @default.
- Q92450363 description "наукова стаття, опублікована 1 травня 2019" @default.
- Q92450363 name "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 name "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 type Item @default.
- Q92450363 label "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 label "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 prefLabel "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 prefLabel "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 P1433 Q92450363-5595D919-91D0-4D4F-83BF-EFEEC0398262 @default.
- Q92450363 P1476 Q92450363-59C41A32-C0CC-4D74-83B7-C9D935A0C77F @default.
- Q92450363 P2093 Q92450363-28CD3FA5-D6DF-499B-B379-C9B2E259A7DF @default.
- Q92450363 P2093 Q92450363-508A31A6-3AAB-48AA-8858-A39CB7393EEA @default.
- Q92450363 P2093 Q92450363-C14C93C3-B430-4E0A-892E-DA89FC09CA7B @default.
- Q92450363 P2093 Q92450363-E02437FB-0938-498B-9685-37DCDA1B1D0D @default.
- Q92450363 P304 Q92450363-3FE0E8F3-B359-4786-A5D7-4A17E7315478 @default.
- Q92450363 P31 Q92450363-AC4E2207-AACF-4FED-8003-480D8B76EB0D @default.
- Q92450363 P356 Q92450363-7EB17137-41C9-4274-956E-7C267BA1D45B @default.
- Q92450363 P433 Q92450363-51320DA6-3170-493C-8E74-84D6BC34BA4E @default.
- Q92450363 P478 Q92450363-81E7C1D5-A89F-456A-85A2-AAAD98CB3167 @default.
- Q92450363 P577 Q92450363-8D02994D-DB12-472E-943B-F7533E62583D @default.
- Q92450363 P698 Q92450363-19720959-76A3-4E5D-A907-A993CE6AD831 @default.
- Q92450363 P356 J.PUROL.2019.04.007 @default.
- Q92450363 P698 31151915 @default.
- Q92450363 P1433 Q27710086 @default.
- Q92450363 P1476 "[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]" @default.
- Q92450363 P2093 "E Baydaroglu" @default.
- Q92450363 P2093 "J Hubert" @default.
- Q92450363 P2093 "P Eschwège" @default.
- Q92450363 P2093 "R El Osta" @default.
- Q92450363 P304 "326-331" @default.
- Q92450363 P31 Q13442814 @default.
- Q92450363 P356 "10.1016/J.PUROL.2019.04.007" @default.
- Q92450363 P433 "6" @default.
- Q92450363 P478 "29" @default.
- Q92450363 P577 "2019-05-01T00:00:00Z" @default.
- Q92450363 P698 "31151915" @default.